Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $108.2800 (-0.82%) ($107.7600 - $109.8900) on Wed. May. 31, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.41% (three month average) | RSI | 51 | Latest Price | $108.2800(-0.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1% a day on average for past five trading days. | Weekly Trend | LGND declines -0.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -0.705% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.705% (StdDev 1.41%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
Resistance Level | $112.47 | 5 Day Moving Average | $110.91(-2.37%) | 10 Day Moving Average | $112.18(-3.48%) | 20 Day Moving Average | $112.47(-3.73%) | To recent high | -5.9% | To recent low | 4.5% | Market Cap | $1.74b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |